The estimated Net Worth of John Francis Cogan is at least 4.64 百万$ dollars as of 4 May 2020. John Cogan owns over 2,416 units of Gilead Sciences stock worth over 4,635,919$ and over the last 19 years John sold GILD stock worth over 0$.
John has made over 43 trades of the Gilead Sciences stock since 2013, according to the Form 4 filled with the SEC. Most recently John exercised 2,416 units of GILD stock worth 47,426$ on 4 May 2020.
The largest trade John's ever made was exercising 110,000 units of Gilead Sciences stock on 7 June 2013 worth over 1,208,900$. On average, John trades about 6,534 units every 37 days since 2005. As of 4 May 2020 John still owns at least 57,276 units of Gilead Sciences stock.
You can see the complete history of John Cogan stock trades at the bottom of the page.
John's mailing address filed with the SEC is 333 LAKESIDE DRIVE, , FOSTER CITY, CA, 94404.
Over the last 22 years, insiders at Gilead Sciences have traded over 221,090,692$ worth of Gilead Sciences stock and bought 30,121 units worth 1,879,767$ . The most active insiders traders include John C Martin、Norbert W Bischofberger、John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of 3,341,365$. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth 51,721$.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: